Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05017701 · ClinicalTrials.gov registry record
Feasibility of Bridge for Post-Operative Pain Management in Hip Arthroplasty
A clinical trial, sponsored by Masimo Corporation.
- Terminated
- Registry status
- 5
- Enrollment target
NCT05017701 is a clinical trial that was terminated before completion, run by Masimo Corporation. The registered enrollment target is 5 participants.
The verdict
NCT05017701 was terminated before completion, sponsored by Masimo Corporation.
- TERMINATED
- Registry status
- 5 participants
- Enrollment target
Study Summary
The aim of this research study is to gather data regarding the feasibility of the Bridge system for the management of pain following total hip arthroplasty (THA).
Interventions
- DEVICE Sham device
- DEVICE Bridge device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2022-04-26 |
| Est. Completion | 2023-05-24 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05017701
The ClinicalTrials.gov registry entry for NCT05017701 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Masimo Corporation, which has 96 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sham device is the first listed.
NCT05017701 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05017701 about?
NCT05017701 is a clinical study titled "Feasibility of Bridge for Post-Operative Pain Management in Hip Arthroplasty". The aim of this research study is to gather data regarding the feasibility of the Bridge system for the management of pain following total hip arthroplasty (THA).
What is the current status of trial NCT05017701?
This trial is currently terminated. The enrollment target is 5 participants. The study started on 2022-04-26. Estimated completion is 2023-05-24.
What interventions are being tested in trial NCT05017701?
The interventions under investigation include: Sham device (DEVICE), Bridge device (DEVICE).
Who is sponsoring clinical trial NCT05017701?
This trial is sponsored by Masimo Corporation, which has 96 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.